Skip to main content

Celontin Prices, Coupons and Patient Assistance Programs

Celontin (methsuximide) is a member of the succinimide anticonvulsants drug class and is commonly used for Seizures.

The cost for Celontin oral capsule 300 mg is around $488 for a supply of 100 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Celontin prices

Oral Capsule

Quantity Per unit Price
100 $4.88 $488.11

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Celontin Coupons, Copay Cards and Rebates

Celontin offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Healthcare providers may request samples of Celontin by contacting PfizerPro via the website or calling 800-505-4426.

Applies to:
Celontin
Number of uses:
Per length of program

Form more information phone: 800-505-4426 or Visit website

Patient Assistance & Copay Programs for Celontin

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Celontin (methsuximide) Capsule

More information please phone: 866-316-7263 Visit Website

Provider: Pfizer RxPathways

Eligibility requirements:
  1. Contact program for details.
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, and patient assistance programs are available for eligible patients. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Celontin (methsuximide) Capsule

More information please phone: 844-989-7284 Visit Website

Provider: Pfizer PAP Connect

Eligibility requirements:
  1. Contact program for details.
  2. At or below 300% of FPL
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Celontin (methsuximide) Capsule

More information please phone: 866-706-2400   or 833-463-0005   Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.